Statistics

Total Visits

Views
Bendamustine in combination with rituximab as first-line treatment for indolent non-hodgkin lymphoma: Retrospective analysis of An Spanish registry87

Select a period of time:

Number of views in the range

Views
Bendamustine in combination with rituximab as first-line treatment for indolent non-hodgkin lymphoma: Retrospective analysis of An Spanish registry25

Views

Views
September 20255
October 20252
November 20253
December 20251
January 202611
February 20260
March 20263
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States15
United Kingdom4
Brazil2
Argentina1
Ecuador1
Egypt1
Finland1
 

Top cities views

Views
San Jose11
Helsinki1
Manaus1
Mãe do Rio1
Quito1